Nilotinib Clinical Trials Nilotinib RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
Condition:   Chronic Myeloid Leukemia, Chronic Phase Interventions:   Drug: HQP1351;   Drug: Hydroxyurea or Interferon-based therapy;   Drug: Homoharringtonine;   Drug: Imatinib, Dasatinib or Nilotinib Sponsor:   Ascentage Pharma Group Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2019 Category: Research Source Type: clinical trials

A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase
Condition:   Chronic Myeloid Leukemia, Chronic Phase Interventions:   Drug: HQP1351;   Drug: Hydroxyurea or Interferon-based therapy;   Drug: Homoharringtonine;   Drug: Imatinib, Dasatinib or Nilotinib Sponsors:   Ascentage Pharma Group Inc.;   HealthQuest Pharma Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2019 Category: Research Source Type: clinical trials